Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 232,329 $ 286,250
Equity method investments 1,386,252 1,279,651
Loans 1,123,000  
Receivables held-for-sale 23,612 0
Real estate 358,405 359,176
Investments 26,147 55,377
Securitization assets 164,955 164,342
Other assets 117,054 100,364
Total Assets 3,431,490 3,459,067
Liabilities:    
Accounts payable, accrued expenses and other 68,276 59,944
Credit facilities 19,509 22,591
Non-recourse debt (secured by assets of $584 million and $723 million, respectively) 462,523 592,547
Senior unsecured notes 1,280,281 1,283,335
Convertible notes 289,580 290,501
Total Liabilities 2,120,169 2,248,918
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 78,319,134 and 76,457,415 shares issued and outstanding, respectively 783 765
Additional paid in capital 1,489,168 1,394,009
Accumulated deficit (181,992) (204,112)
Accumulated other comprehensive income (loss) (5,359) 12,634
Non-controlling interest 8,721 6,853
Total Stockholders’ Equity 1,311,321 1,210,149
Total Liabilities and Stockholders’ Equity 3,431,490 3,459,067
Government receivables    
Assets    
Loans 135,054 248,455
Commercial receivables    
Assets    
Loans $ 987,682 $ 965,452